BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1909 related articles for article (PubMed ID: 16938321)

  • 1. Nitric oxide donors prevent while the nitric oxide synthase inhibitor L-NAME increases arachidonic acid plus CYP2E1-dependent toxicity.
    Wu D; Cederbaum A
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):282-92. PubMed ID: 16938321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The liver-selective nitric oxide donor O2-vinyl 1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (V-PYRRO/NO) protects HepG2 cells against cytochrome P450 2E1-dependent toxicity.
    Gong P; Cederbaum AI; Nieto N
    Mol Pharmacol; 2004 Jan; 65(1):130-8. PubMed ID: 14722244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposite action of S-adenosyl methionine and its metabolites on CYP2E1-mediated toxicity in pyrazole-induced rat hepatocytes and HepG2 E47 cells.
    Wu D; Cederbaum AI
    Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G674-84. PubMed ID: 16306132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine A protects against arachidonic acid toxicity in rat hepatocytes: role of CYP2E1 and mitochondria.
    Wu D; Cederbaum AI
    Hepatology; 2002 Jun; 35(6):1420-30. PubMed ID: 12029627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic toxicity of iron and arachidonic acid in HepG2 cells overexpressing CYP2E1.
    Caro AA; Cederbaum AI
    Mol Pharmacol; 2001 Oct; 60(4):742-52. PubMed ID: 11562436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Green tea polyphenol epigallocatechin-3-gallate protects HepG2 cells against CYP2E1-dependent toxicity.
    Jimenez-Lopez JM; Cederbaum AI
    Free Radic Biol Med; 2004 Feb; 36(3):359-70. PubMed ID: 15036355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of phosphatidylinositol 3-kinase/AKT as a survival pathway against CYP2E1-dependent toxicity.
    Caro AA; Cederbaum AI
    J Pharmacol Exp Ther; 2006 Jul; 318(1):360-72. PubMed ID: 16624972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum deprivation-induced HepG2 cell death is potentiated by CYP2E1.
    Zhuge J; Cederbaum AI
    Free Radic Biol Med; 2006 Jan; 40(1):63-74. PubMed ID: 16337880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide from the inducible nitric oxide synthase (iNOS) increases the expression of cytochrome P450 2E1 in iNOS-null hepatocytes in the absence of inflammatory stimuli.
    Zamora R; Vodovotz Y; Alarcon L; Betten B; Loughran PA; Aulak KS; Stuehr DJ; Gibson KF; Billiar TR
    Arch Biochem Biophys; 2001 Jun; 390(2):287-94. PubMed ID: 11396931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of nitric oxide and nuclear factor-kappaB in the CYP2E1 potentiation of tumor necrosis factor alpha hepatotoxicity in mice.
    Wu D; Xu C; Cederbaum A
    Free Radic Biol Med; 2009 Feb; 46(4):480-91. PubMed ID: 19063961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of glutathione produces apoptosis and necrosis in HepG2 cells overexpressing CYP2E1.
    Wu D; Cederbaum AI
    Alcohol Clin Exp Res; 2001 Apr; 25(4):619-28. PubMed ID: 11329505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nrf2 and antioxidant defense against CYP2E1 toxicity.
    Cederbaum A
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1223-44. PubMed ID: 19671018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C signaling as a survival pathway against CYP2E1-derived oxidative stress and toxicity in HepG2 cells.
    Jimenez-Lopez JM; Cederbaum AI
    J Pharmacol Exp Ther; 2005 Mar; 312(3):998-1006. PubMed ID: 15494549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased toxicity by transforming growth factor-beta 1 in liver cells overexpressing CYP2E1.
    Zhuge J; Cederbaum AI
    Free Radic Biol Med; 2006 Oct; 41(7):1100-12. PubMed ID: 16962935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated expression of Cu/Zn- or Mn-superoxide dismutase protects against CYP2E1-dependent toxicity.
    Pérez MJ; Cederbaum AI
    Hepatology; 2003 Nov; 38(5):1146-58. PubMed ID: 14578853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide synthase inhibitors modulate lipopolysaccharide-induced hepatocyte injury: dissociation between in vivo and in vitro effects.
    Farghali H; Canová N; Kucera T; Martínek J; Masek K
    Int Immunopharmacol; 2003 Nov; 3(12):1627-38. PubMed ID: 14555288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the catalytic activity of alcohol dehydrogenase by nitric oxide is associated with S nitrosylation and the release of zinc.
    Gergel D; Cederbaum AI
    Biochemistry; 1996 Dec; 35(50):16186-94. PubMed ID: 8973191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is nitric oxide luteolytic or antiluteolytic?
    Weems YS; Lennon E; Uchima T; Raney A; Goto K; Ong A; Zaleski H; Weems CW
    Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):129-38. PubMed ID: 16303611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide modulates air embolism-induced lung injury in rats with normotension and hypertension.
    Liu YC; Kao SJ; Chuang IC; Chen HI
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1173-80. PubMed ID: 17880373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress mediated toxicity exerted by ethanol-inducible CYP2E1.
    Wu D; Cederbaum AI
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):70-6. PubMed ID: 16019049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 96.